Related Experiment Video

Updated: Aug 1, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

[Clinical-immunological research in chronic inflammatory diseases of the biliary tract]

A V Iepishyn1, P Ia Sherstiuk, N A Khabarova

  • 1Kafedra propedevtyky vnutrishnikh khvorob, kafedra terapiï FPO Ternopol'skoï medychnoï akademiï im. I.Ia. Horbachevs'koho.

Klinichna Khirurhiia
|January 1, 1997
PubMed

Insights

Immune system changes in chronic biliary diseases include reduced T-cells and increased B-cells, antibodies, and immune complexes. Gallstones and coexisting conditions worsen these immune alterations.

Area of Science:

  • Immunology
  • Gastroenterology
  • Hepatology
  • Pathophysiology

Context:

  • Investigated the immune status of 123 patients diagnosed with chronic inflammatory diseases of the biliary system (CDBS).
  • Focused on alterations during the acute phase of the disease.
  • Examined the influence of specific complications like gallstones and coexisting liver or pancreatic inflammation.

Purpose:

  • To conduct a comprehensive analysis of the immune system's state in patients with CDBS.
  • To identify specific immune markers and their changes associated with chronic biliary inflammation.
  • To assess how complications like cholelithiasis, reactive hepatitis, and pancreatitis impact immune dysregulation.

Summary:

  • Observed a decrease in T-lymphocyte quantity and functional activity, including subpopulations.
  • Noted a reduction in complement levels and blood serum lysozyme.
  • Documented an increase in B-lymphocytes, serum IgG and IgM, circulating immune complexes (CIC), and antibody titers against gallbladder, liver, and pancreas tissues, alongside heightened lymphocyte sensitization to these antigens.

Impact:

  • Revealed significant immune dysregulation in CDBS patients, characterized by both cellular and humoral immune system impairments.
  • Highlighted that the presence of gallstones and concurrent conditions like reactive hepatitis or pancreatitis exacerbates immune system changes.
  • Provides crucial insights into the complex immunological landscape of biliary tract diseases, potentially informing diagnostic and therapeutic strategies.

More Related Videos

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...